U.S. News & World Report: Smoking residue on household surfaces can harm kids
Tobacco researcher Ashley Merianos leads study of thirdhand smoke in homes where children reside
A new study by UC tobacco researcher Ashley Merianos was featured in U.S. News & World Report.
The study measured the amount of nicotine and tobacco related toxins on surfaces in smoking households where children reside. The residue that remains on surfaces such as walls, tables, floors and decor is called thirdhand smoke.
Ashley Merianos is an associate professor in UC's school of Human Services
Merianos led a research team that tested homes of 84 children found nicotine on surfaces in every home, and nearly half had detectable levels of a tobacco-specific carcinogen called NNK. Residue was also found in households with indoor smoking bans.
"This is critically important and concerning," said Merianos, an associate professor in the College of Education, Criminal Justice and Human Services.
Merianos is a research affiliate member of Cincinnati Children’s Hospital Medical Center, the Thirdhand Smoke Research Consortium and the American Academy of Pediatrics Tobacco Consortium.
Featured image at top of cigarette and ashtray. Photo/iStock/Kotlyarchuk
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Related Stories
UC alumni-led band The National named among greatest living American songwriters
June 4, 2026
UC-connected band The National, co-founded by DAAP alumni, has been named to The New York Times Magazine readers’ list of the 100 Greatest Living American Songwriters.
UC expert explains how provocateurs try to manipulate conflict
June 4, 2026
UC Professor Jeffrey Blevins talks to the Dallas Morning News about how outside agitators seize on tragedy to push their agendas.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.